SCHEMBL18833366

SCHEMBL18833366

CCOc1nc(I)ccc1C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.38
CFTR P13569 1/20 0.36
CNR2 P34972 7/20 0.36
CTSS P25774 2/20 0.34
TRPA1 O75762 1/20 0.34
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE1C Q14123 1/20 0.33
CTSK P43235 1/20 0.32
KDM4E B2RXH2 3/20 0.32
HPGD P15428 2/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CNR1 P21554 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GLA P06280 1/20 0.32
HTR6 P50406 1/20 0.32
KCNK3 O14649 1/20 0.32
KCNK9 Q9NPC2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17707980 0.81 NPC1 (0.41) CDK1CFTRCNR2CTSSTRPA1
SCHEMBL1858748 0.79 CFTR (0.41) CDK1CFTRCNR2CTSSTRPA1
SCHEMBL23166258 0.73 KMT2A (0.39) KDM4EHPGDKMT2AMEN1SMN1; SMN2
SCHEMBL2387153 0.71 SLC22A12 (0.46)
SCHEMBL1850824 0.71 KDM4E (0.40) KDM4EHPGDKMT2AMEN1SMN1; SMN2
SCHEMBL4148746 0.70 MEN1 (0.36) KDM4EHPGDKMT2AMEN1NPSR1
SCHEMBL17777195 0.70 CYP11B1 (0.33) KDM4EKMT2AMEN1NPSR1
SCHEMBL3963652 0.69 CTSK (0.38) CTSKKDM4EHPGDSMN1; SMN2
SCHEMBL30115270 0.69 SMN1; SMN2 (0.39) CDK1CFTRCTSSTRPA1KDM4E
SCHEMBL25413494 0.69 CFTR (0.34) CDK1CFTRCTSSTRPA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3004107-B1 6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS JANSSEN PHARMACEUTICA NV (BE) 2017-05-10 EP disclosed